- Provention Bio (PRVB) +263% on ~$2.9B acquisition by Sanofi.
- Calliditas Therapeutics (CALT) +29% announces primary endpoint successfully Met in phase 3 NefIgArd trial evaluating Nefecon® in IgA Nephropathy.
- Caleminder (CMND) +27%.
- Seagen (SGEN) +18% Pfizer to acquire cancer drugmaker Seagen for $43B.
- Appreciate Holdings (SFR) +15%.
- InMed Pharmaceuticals (INM) +14%. on announcing publication of peer-reviewed study showing the anti-Inflammatory potential of rare cannabinoids in skin conditions.
- ZIM Integrated Shipping Services (ZIM) +11% on Q4 earnings.
- Harmony Gold Mining (HMY) +11% Miners rise with gold and silver prices on bank sector worries, jobs data.
- Gold Fields (GFI) +10% Miners rise with gold and silver prices on bank sector worries, jobs data.
- Lucy Scientific Discovery (LSDI) +9%.
- AngloGold Ashanti (AU)+8% Miners rise with gold and silver prices on bank sector worries, jobs data.
- Bakkt Holdings (BKKT) +8%.
- HIVE Blockchain Technologies (HIVE) +8%.
- Bit Digital (BTBT) +8%.
- Illumina (ILMN) +8% Carl Icahn said to prepare for proxy battle with Illumina over Grail deal - WSJ.
- BILL Holdings (BILL) +7% Payoneer, Unity Software, BILL among others to disclose exposure to Silicon Valley Bank.
- Qualtrics International (XM) +6% agrees to $12.5B sale to Silver Lake.
- enCore Energy (EU) +6%.
- MicroStrategy (MSTR) +7%.
- Hut 8 Mining (HUT) +6% provides update on business combination with USBTC.
- Fortuna Silver Mines (FSM) +5% reports Sunbird infill drilling results at Séguéla, Côte d´Ivoire.
- Kinross Gold (KGC) +5% Gold miners on the move in safe-haven trade amid SVB collapse.